The Team Behind H.A.L.O. Wins UHN’s Inventor of the Year Award

Why It Matters

H.A.L.O.’s adoption demonstrates how remote monitoring can reduce adverse events and lower hospital costs, accelerating the shift toward virtual care. The award validates the commercial viability of clinician‑driven innovations in the Canadian health system.

Key Takeaways

• H.A.L.O. monitors high‑risk patients remotely from central hub
• Deployed across 50 units, delivering measurable cost savings
• Interdisciplinary team includes clinicians, engineers, and health‑tech partners
• Award highlights successful bedside‑to‑market commercialization pathway
• Scalable model positions H.A.L.O. for national expansion

Pulse Analysis

Remote patient monitoring has moved from niche pilots to a cornerstone of modern hospital operations, driven by rising demand for continuous safety oversight and cost containment. High‑risk populations—such as transplant candidates, dementia patients, and those prone to falls—benefit from real‑time visual and audio surveillance, reducing preventable incidents while freeing bedside staff for higher‑value tasks. Industry analysts note that platforms capable of scaling across facilities are reshaping the economics of acute care, positioning digital health firms for rapid adoption in both public and private sectors.

H.A.L.O. originated from a simple camera‑and‑speaker setup on an IV pole in Toronto General Hospital’s thoracic surgery unit, where nurse practitioner Marijana Zubrinic and surgeon Dr. Shaf Keshavjee sought to prevent safety events among lung‑transplant candidates. After a life‑saving pilot in 2015, the concept evolved with TECHNA engineers and Altum Health collaborators into a fully operational company by early 2025. Today, the platform runs in 50 inpatient units, delivering measurable efficiency gains, lower staffing overhead, and reduced adverse events, while generating a new revenue stream through virtual care services offered beyond UHN’s network.

The Mission of Excellence Team Inventor of the Year Award spotlights H.A.L.O.’s successful translation from bedside innovation to market‑ready solution, illustrating a replicable pathway for clinician‑led entrepreneurship. Recognition by UHN not only affirms the clinical impact but also signals to investors and health systems that home‑grown digital tools can achieve commercial scale. As hospitals nationwide grapple with staffing shortages and rising costs, H.A.L.O.’s scalable architecture positions it for broader Canadian rollout and potential export, reinforcing the strategic importance of integrated health‑tech ecosystems.